CA2012395A1 - Topical analgesic composition - Google Patents

Topical analgesic composition

Info

Publication number
CA2012395A1
CA2012395A1 CA002012395A CA2012395A CA2012395A1 CA 2012395 A1 CA2012395 A1 CA 2012395A1 CA 002012395 A CA002012395 A CA 002012395A CA 2012395 A CA2012395 A CA 2012395A CA 2012395 A1 CA2012395 A1 CA 2012395A1
Authority
CA
Canada
Prior art keywords
solution
trolamine
mixture
acid
parahydroxybenzoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002012395A
Other languages
French (fr)
Inventor
Jeffrey Wenig
Vincent Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2012395A1 publication Critical patent/CA2012395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ABSTRACT OF
THE
DISCLOSURE

Flowable, aqueous, analgesic solutions containing substantially equimolar quantities of trolamine and salicylic acid together with a lower alkanol, a lower alkylene glycol and a lower alkyl ester of parahydroxybenzoic acid and water, and method for the preparation thereof.

Description

r-Trolamlne sali~ylat- ha~ long b-sn known a~ a topl~-l ~n~lge~lc for temporary ~Qll~f o~ mu~culo~kol~t-l ~ch-~ and paln-q ~peclally tho~e a~soci~ted wlth tra~n~, ~praln~, brulo-~ or ov~r-xcrtion, t ha~ alno b-on recomm-nd-d ~or ~empo~ary allovlation o~ arthritlc ~nd rh~umatlc paln oDp~cially ln th-h~nds and ~--t. It 18 ~peclally favor~d by atnlete~

Trolamine ~allcylAte 1~ a l:l complex formad by r-actlon o~
~qulmo~ar qu~ntitl~ of ~allcyllc acld ~nd trol~mlne (t~l-th~nol amln~ ho analgesic a~-nt 18 the ~allcyllc acld which fo~m~ tn JltU when th- Jalt cro~ th~ ~kln barrl-r, The prlnclpal da~ld-ratum of toplcal analge~lc~ 1~ r~pld p-n-tr~tlon of the ~ln barrler to th- r-glon of th~ paln. To thlJ cnd, a variety o~ toplcal cr-am-~ lotiono, ~02m~ and othar vl~cou~ oomposltlon~ hav- ~oon provid-d contalning a larg- numbe~
o~ omoli-nt-, suopon~lng agent~, eh-lating agents, ~t~ nlng ag-nt~, omulsirl~r6, olls, buf~-rln~ agent4 and oth-r component~
lnc~udlng, 80 call-d ol~agonou~ v-hlcle~ hav~ bo-n provlded, app~r~ntly in tho b-lle~ ~hat ~uch lngr~d~ont~ ~ro n0cos~ary ~or r-pld penotrEtlon o~ th- ~kin barr~-r.

Th~- vl~cou~ compo-ltion~ ar- o~ten di~flcult to apply and r~qulre xt~nslv~ "ru~blng ln". Thl~ may be burd~n~om~, -p-clally lf ~oth hands ar~ ~ff-cted, o~ lf th- aff-cted ar~a 1 h-rd to r-ach ~uch ~Q the ~r of th~ ~houlter ar-~.
Addltlo~ally~ the cr~am may 1~aY~ un-~ght~y raoldu~ on ths 4~1n or thoy may tain th~ clothl~g. Oft-n, -p~clally lf u~-d by nn athl-t~ ~urlng comp~tltlon thoy may ab~orb ~lr-~orn~ du~t and p-rtlcles and b-com~ n more unst~htly~ Mor-o w r, on~ or mor-of the compon-nt~ m~y b- allorg~nlc.

. .

20~3~5 .
Th~ a~t h~ long ~earch-d ~or compo~ltlon- whlch can b~
u~erully mploy~d whil~ avoiding th~ ~bove mentionod icultl~.

' .

It ha~ now b--n dl~cov-r-d that ~ ~eapito th- lndl~atlon~
from the ~rt, aqu-ou~ oolutlon~ con~inin~ t~ol~m~n- ~all~yla~e n--d ~ot contaln the larg- numbo~ of lngr-dl-~t~ pr~vlo~ly mployed, but th~t th~ anAl~o~lc may b~ promptly and e~ ien~ly d-llver~d to tho ~lt~ wh~ro it i3 naed6d ~rom ~ Garrlor baYe that contain~ only w~tor, ~ pr~a-r~ti~e, ~ low~r alkanol, ~nd A low mol-c~ wolght glycol. Th~ ~ctlv- l~gr~dlent w~ll r~pldly ~ -pon~trate th- ~ln barrl~r to prov~ a prompt ~oothlng analgeoic aetlon de~plt- tho absenc- o~ the oll~, ~mulsl~lar~ ~nd oth~r xcipient~ norm~lly employ-d with trolamln- ~-licylAt-.

~ h~ compo~itlon. o~ th- inYentlon ar- ~low~bl- ~ompo~ltlon~
wlth a vl~co~ty at dmbl-nt t~mper~ture whloh 1~ ~out th~t of w~ter, 1,~. ~bout 0.58 to 1.2 time~ th~ v~co~ity o~ water.
B~cau~e th-y are re~dlly flowable, 1.~., "llk- wat~r", tney may be ~a~lly And convonl-ntly ~ppll~d by a ~-ry brief rubblng. Th-y are r-~d~ly appll-~ ~om ea~lly d-~gn-d cont~l~er8 ~uch ~
~-rosol, bru~h or spongo ~ppllcator~. Tha volum- Or ~olutlon p-e~lng through tho Appllcator c~n be controll~ by ~ny o~
numbe~ o~ v~lve mean~ w-ll known to tho~ d in tno art, Some appllc~tor~ may ov-n ellminat- th- n-~d ~or touchlng th~
compo~ltlon~ of tho in~ent~on ~urtng ~ppllcat~on.

Tho ~ormatlo~ of th- trol~mine ~allcyl~t- ~omplsx ~3 ~n qulmolar r~ctlon. Acco~dlngly the compo~ltlon~ will ~ontaln ~ub~t~ntlally e~ulmol~r quantlt~a~ o~ the ~n~lg-~lc ~Cld and th- :~
b-Jo. ~t 1- pro~rre~ to omploy ~ ght molsr xc~o~, 4ay 1~ to Z01~39S
10~, o~ th~ ba9e to insur~ th~t all 4~ the acld will r4act an~
301ubillz~, The amount of trolamlne wlll vAry ~rom ~bout 5 to 12~, and of ~allcylic acid from about 3 to lO~ by w~i~ht bo~ed on tho total volum- o~ ~o oompo~tlon.

In thl- dl3closu~0 ond clolm~, all de~ined amount~ Aro tn p-rcont by w-ight ba~ad on tho total volume.

Tho alkonol dmployod in th~ oomposltlonJ will contaln two o~
~hree corbon atom~ ~nd b~ misclbl- wlth wat~r. Such alcohols hsve Low ~o~ling polnta and hlgh vapor p~e~sura. Th-y promo~e ropld ~vaporation of th~ carrier v~hiol- ot ~he compo~ltion. The amou~t o~ alcohol employed lo typlo~lly ~rom about 3 to 6~.

Th- pref~rr~d alkanol i~ l~opropyl alcohol. M~xtures of alcohol~ w~ich ~oy contoln eth~nol moy b~ ~m~loy~d.

Tho compoJltion- ol the inv~ntlon wSll al~o cont-in A
pre~orv~ttve. Th- pr~o~tly pr-~-rr-d pre~rv~tlv-~ arc low~r al~yl -ter~ of psrAhydroxyb-nzolc ocid, typlo~lly contalning up to thræe carbon atom~, Th~ ~mount of pr-~arvatlv~ normally employed will b~ ~rom about 0.1 to 0.5~, olthough wld- vorlation~
~re po~lble wlthout adverse re~ult~. The ~Jtar~ may be ~mploy-d lngly, but lt i~ pr-~rr~d to u~- a mlxture o~ m-thyl and propyl o~ter~ o~ p~rahydroxyben201c acl~ ~lnce tho mlxturo app~ar~ to ~e moro ctlve than lt~e~ e~t~r t~ken ~lono.

Propyleno glycol~ or mlxtures ther~o~ are UtlllZ-~ ~n the compo~ltlons o~ tho lnventlon ~- a ~olublll2~r for th~
pro~orvative ~y-t-m ln an amount of from ~out 2.5 to 6~. The compo~ltlon8 of thl~ invontlon are solution~. It i~ lmport~nt th~t ~11 of th- ~olid compon-~to dlJ~olv-~ A su~ficl-nt amount of glycol 1~ mployed to ln~ure ~uch ~olublllty, but too much - . ~ " j . . .

~ \

glycol m~y incr~a~ the vi~co~ty of the composltion and ~tlll decr~a~- the rata o~ evaporatlon rom ~he skln. ~h- pro~errod g~ycol 1~ 1,2-propan~ dlol.

~ g lndlcAted abov-, the c~mpon-nt~ Or the mlxtur~ mu~t rorm a oolutlon. It ha~ b--n dl~ov~r-d th~t th~ ~ethod o mlxlng i~
very lmport~nt to pr-v-nt pr~lplt~t~on o~ the ~olld compon-nt~.
In th~ pr-~orred procod~ro, th~ trol~mln- And ~allcyllo a~ld ~r-~dded ~t amb~-nt temp~r~ture to th~ ct-d quantlty of wat~r, which may be ~ll of th~ water employ~d ln th- compo~lt~on, and the mlxtur~ 18 allow-~ to stand untll complete ~olut~on 1~
e~f~ct~d. A socond mlxtura contalnlng th~ aelect~d quantltl~s of glycol and al~yl ~te~(~) o~ p~r~hydroxybenzolc acld, ~.q., mlxture o~ ~h- m~thyl and propyl estor 1~ ~-p~r~t~ly prep~r~d ~nd ~lowly adde~ to th- ~lr~t ~olutlon. I~ lt 1~ added too rapi~ly, lt wlll c~u3e preclpltation o~th- ~llcyl~c acid ~nd/or the alkyl o~ter o~ parahydroxyb-nzoic acid. Th~ glycollpreoe~vatlv-m$xtu~e may con~in ~omo o~ tho water of th- ~lnal compo~lt~on.
Th- select~d quantlty o~ alkanol 1~ th~n ~ddcd ~o ehe mlxtur-.

Th~ p~ o~ th~ composlt~on~ oS thl~ inventlon ar- preSerably a~ clo~c to n~utr~l a8 po4~1bl-, but a range oS 6 to 8, or evan ~llghtly wld~r c~n be to1crat-d.

It 1~ surprl~l~g to ob-~rve how qulckly the actlve ln~r-dlent penotr~tes th~ a~ln basrl~r ~rom th- ~olutlon~ o~ thls lnvention. Athl-t-~ hav~ b--n partlcul~rly ~-tl~led. ~h~y hdv~
ob~-rv-d rel~o~ ~rom musoular paln o~ the arm~ sn~ leg~ withln few mlnute4 a~t-r toplcal ppllcation.

The.~ollowlng ~ormulatlon~ A ~nd B axo repre~ntatlv~ o~ the ~n-lgo~lc compo~ltlon~ o~ the i~vontlon.
, 1 ' ' ' . ' . ' ' '' " ' ' '' '" ' ' ' "' ' ; ' . , ' ' ~ :
2 01~ 3 95 ~ w/v trol~mln- 99~ N.F. 5.76 ~allcylle ~ld U.S.P. 4~1 m~thyl parahydroxyb~201c aci~, N,F. 0.2 propyl p~rahydroxybenzoic acid, N.F, 0.1 propylane ~lycol U.S.P. 3.0 lsopropyl ~lcohol U.S.P. 3.0 wat~r U.S.P. ~3.13 qr~ms trolaml~e 9g~ N.F. 28. ~0 salleyllc ~ld U.~P. 2~05 methyl par~hydroxybenzole ~c~d, N.F. 1,00 propyl par~hydroxyben20~e ~cld~ N~F. 0.50 propylen~ glyeol U.~.P. 15.00 i~opropyl ~lcohol U.S.P. lS,00 wat~r U,S,P, ~1S.6S ~:.

For com~o~ltlon A, th- trolamlne, 50~ o~ th~ volume of wat~r ~nd thc ~llcjlic ael~ ~-ro ~tirro~ ~t room t-mporatur~ uns1l th- . :
~alleylic ~eid dl~-olv d. In ~ s~par~t- v~ l, th~
pr~J-rvatlve~ war- d~ol~d in propylo~e qlycol and th~
~olution ~d~ed ~lowly to th~ ~lr~t mlxtu~e wlth ~t~:rlng. ~hen ~:~
th~ addlt~on wa~ compl-t~, tho alcohol w~ ~dd~d ~ollowod by th- ::
b~l~ne- o~ tho w-t-r whlle contlnually Jtlrring. :

- 5 ~

20~239.~

CompoNltlon B tqa~ ~imil~rly prepar~d.

Claims (9)

1. A flowable, analgesic, aqueous solution having a pH
of from about 6 to 8, a viscosity of from about 0.98 to 1.2 times that of water and containing, from, about 5 to 12% trolamine, about 3 to 10% salicylic acid, about 0.1 to 0.5% of a lower alkyl ester of parahydroxybenzoic acid, abut 2.5 to 5% of a propylene glycol or mixtures thereof, and about 3 to 6% of an alkanol containing two or three carbon atoms, the salicyclic acid and trolamine being present in substantially equimolar quantities.
2. A solution of claim 1 containing from 1% to 10%
molar excess of trolamine.
3. A solution of claim 1 or 2 wherein the alkyl group of the lower alkyl ester of parahydroxybenzoic acid contains up to three carbon atoms.
4. A solution of claim 1 or 2 wherein the propylene gylcol in 1,2-propane diol.
5. A solution of claim 1 or 2 containing a mixture of methyl and propyl esters of parahydroxybenzoic acid.
6. A solution of claim 1 or 2 containing a mixture of ethyl and isopropyl alcohol.
7. A solution of claim 1 or 2 containing a mixture of methyl and propyl parahydroxybenzoic acid together with, isopropyl alcohol, and 1,2-propane diol.
8. A method for the preparation of an aqueous solution of claim 1 dissolving the trolamine and salicylic acid in a portion of the total water of the solution which will dissolve all of the trolamine and salicylic acid to form a first mixture, separately forming a second mixture containing the lower alkyl ester of parahydroxybenzoic acid and the alkylene glycol;
combining the first and second mixtures at a rate which is insufficient to cause precipitation of any solid and thereafter adding the alkanol and any additional water necessary to form the said aqueous solution.
9. A method of claim 8 employing from 1% to 10% molar excess of trolamine.
CA002012395A 1989-03-17 1990-03-16 Topical analgesic composition Abandoned CA2012395A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32491289A 1989-03-17 1989-03-17
US07/324,912 1989-03-17

Publications (1)

Publication Number Publication Date
CA2012395A1 true CA2012395A1 (en) 1990-09-17

Family

ID=23265643

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002012395A Abandoned CA2012395A1 (en) 1989-03-17 1990-03-16 Topical analgesic composition

Country Status (5)

Country Link
EP (1) EP0417245A4 (en)
JP (1) JPH03504610A (en)
AU (1) AU5341390A (en)
CA (1) CA2012395A1 (en)
WO (1) WO1990011014A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697043B1 (en) * 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA613768A (en) * 1961-01-31 P. Modderno John Topical analgesic compositions
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4511563A (en) * 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness

Also Published As

Publication number Publication date
JPH03504610A (en) 1991-10-09
WO1990011014A1 (en) 1990-10-04
AU5341390A (en) 1990-10-22
EP0417245A1 (en) 1991-03-20
EP0417245A4 (en) 1991-09-18

Similar Documents

Publication Publication Date Title
CA1280975C (en) Method and compositions for making liposomes
ES2224651T3 (en) METHOD FOR STABILIZING PHARMACEUTICAL COMPOSITIONS THROUGH THE SPECIAL USE OF AN ANTIOXIDANT.
ES2089011T3 (en) LIPIDIC EXCIPIENT OF NASAL ADMINISTRATION AND TOPICAL APPLICATION.
US5895789A (en) Parenteral pharmaceutical compositions containing ammoniomalkyl salts of 2-arylpropionic acids
DE50005515D1 (en) MECHANICALLY STABLE PHARMACEUTICAL PHARMACEUTICAL FORM, CONTAINING LIQUID OR SEMI-SOLID SURFACE-ACTIVE SUBSTANCES
BR0108438A (en) Pharmaceutical Composition
IE61068B1 (en) Mixed micelle solutions containing non-steroidal anti-inflammatories
MXPA06001054A (en) Bioactive compositions comprising triazines.
PT723437E (en) PHARMACEUTICAL PREPARATION BY MULTIPLE UNITS CONTAINING AN INHIBITOR OF THE PUMP PUMP
ES2356704T3 (en) PERCUTANEOUSLY ABSOBIBLE PREPARATIONS.
KR960705585A (en) PERSONAL COMPOSITION AND PERNASAL PREPARATION CONTAINING THE SAEM
CN1364079A (en) Transnasal anticonvulsive compositions and modulated process
FI102873B (en) Process for producing nitroglycerin-containing, hydrophilic, water-soluble pump spray
ES2627409T3 (en) Acetaminophen Stabilizer
PT916347E (en) INJECTABLE PHARMACEUTICAL SOLUTIONS CONTAINING PARACETAMOL AND PARACETAMOL COMBINATIONS WITH OTHER ACTIVE SUBSTANCES
LT4585B (en) Local anesthetic for external use
BR0009765B1 (en) L-CARNITINE OR ALCANOIL L-CARNITINASE ESTER COMPOUNDS, USE OF THE SAME, LIPOSOMES CONTAINING THESE COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THESE LIPOSOMES.
US6538030B2 (en) Treating radiation fibrosis
ITMI970408A1 (en) GELIFIED NIMESULIDE SYSTEMS FOR TOPICAL USE
CA2012395A1 (en) Topical analgesic composition
Bakshi et al. A novel metered dose transdermal spray formulation for oxybutynin
AU698131B2 (en) Transdermal delivery of anti-epileptic drugs
KR20060013378A (en) Composition for injection
JPH0764754B2 (en) Transdermal absorption enhancer and external preparation for skin containing the same
ES2244043T3 (en) COMPOSITION LIOFILIZED MP52 HUMAN OF MORPHOGENETIC FACTOR OSEO.

Legal Events

Date Code Title Description
FZDE Dead